BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

526 related articles for article (PubMed ID: 9933348)

  • 21. Reirradiation of recurrent high-grade gliomas using amino acid PET (SPECT)/CT/MRI image fusion to determine gross tumor volume for stereotactic fractionated radiotherapy.
    Grosu AL; Weber WA; Franz M; Stärk S; Piert M; Thamm R; Gumprecht H; Schwaiger M; Molls M; Nieder C
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):511-9. PubMed ID: 16168843
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PET and SPECT for detection of tumor progression in irradiated low-grade astrocytoma: a receiver-operating-characteristic analysis.
    Henze M; Mohammed A; Schlemmer HP; Herfarth KK; Hoffner S; Haufe S; Mier W; Eisenhut M; Debus J; Haberkorn U
    J Nucl Med; 2004 Apr; 45(4):579-86. PubMed ID: 15073253
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of size of regions of interest on the measurement of uptake of 123I-alpha-methyl tyrosine by brain tumours.
    Kuwert T; Morgenroth C; Woesler B; Matheja P; Palkovic S; Vollet B; Schäfers M; Wassmann H; Schober O
    Nucl Med Commun; 1996 Jul; 17(7):609-15. PubMed ID: 8843121
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oligodendroglial component complicates the prediction of tumour grading with metabolic imaging.
    Manabe O; Hattori N; Yamaguchi S; Hirata K; Kobayashi K; Terasaka S; Kobayashi H; Motegi H; Shiga T; Magota K; Oyama-Manabe N; Nishijima K; Kuge Y; Tamaki N
    Eur J Nucl Med Mol Imaging; 2015 May; 42(6):896-904. PubMed ID: 25647076
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Noninvasive grading of untreated gliomas: a comparative study of MR imaging and 3-(iodine 123)-L-alpha-methyltyrosine SPECT.
    Riemann B; Papke K; Hoess N; Kuwert T; Weckesser M; Matheja P; Wassmann H; Heindel W; Schober O
    Radiology; 2002 Nov; 225(2):567-74. PubMed ID: 12409596
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Application of SPET using technetium-99m sestamibi in brain tumours and comparison with expression of the MDR-1 gene: is it possible to predict the response to chemotherapy in patients with gliomas by means of 99mTc-sestamibi SPET?
    Yokogami K; Kawano H; Moriyama T; Uehara H; Sameshima T; Oku T; Goya T; Wakisaka S; Nagamachi S; Jinnouchi S; Tamura S
    Eur J Nucl Med; 1998 Apr; 25(4):401-9. PubMed ID: 9553170
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Value of 123I-IMT SPECT for diagnosis of recurrent non-astrocytic intracranial tumours.
    Plotkin M; Amthauer H; Eisenacher J; Wurm R; Michel R; Wust P; Stockhammer F; Röttgen R; Gutberlet M; Ruf J; Felix R
    Neuroradiology; 2005 Jan; 47(1):18-26. PubMed ID: 15630586
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Uptake of DL-3-123I-iodo-alpha-methyltyrosine in recurrent brain tumors].
    Guth-Tougelidis B; Müller S; Mehdorn MM; Knust EJ; Dutschka K; Reiners C
    Nuklearmedizin; 1995 Apr; 34(2):71-5. PubMed ID: 7761277
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Optimization of semi-quantification in metabolic PET studies with 18F-fluorodeoxyglucose and 11C-methionine in the determination of malignancy of gliomas.
    Borbély K; Nyáry I; Tóth M; Ericson K; Gulyás B
    J Neurol Sci; 2006 Jul; 246(1-2):85-94. PubMed ID: 16603193
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Investigation of iodine-123-labelled amino acid derivatives for imaging cerebral gliomas: uptake in human glioma cells and evaluation in stereotactically implanted C6 glioma rats.
    Samnick S; Richter S; Romeike BF; Heimann A; Feiden W; Kempski O; Kirsch CM
    Eur J Nucl Med; 2000 Oct; 27(10):1543-51. PubMed ID: 11083545
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of the extension of cerebral gliomas by scintigraphy.
    Weckesser M; Matheja P; Rickert C; Löttgen J; Palkovic S; Riemann B; Paulus W; Wassmann H; Schober O
    Strahlenther Onkol; 2000 Apr; 176(4):180-5. PubMed ID: 10812391
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The in vivo metabolic pattern of low-grade brain gliomas: a positron emission tomographic study using 18F-fluorodeoxyglucose and 11C-L-methylmethionine.
    Derlon JM; Petit-Taboué MC; Chapon F; Beaudouin V; Noël MH; Creveuil C; Courtheoux P; Houtteville JP
    Neurosurgery; 1997 Feb; 40(2):276-87; discussion 287-8. PubMed ID: 9007859
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Contribution of nuclear medicine to the diagnosis of recurrent brain tumors and cerebral radionecrosis].
    Bader JB; Samnick S; Schaefer A; Hagen T; Moringlane JR; Feiden W; Piepgras U; Kirsch CM
    Radiologe; 1998 Nov; 38(11):924-9. PubMed ID: 9861652
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correlation between postoperative 3-[(123)I]iodo-L-alpha-methyltyrosine uptake and survival in patients with gliomas.
    Weber WA; Dick S; Reidl G; Dzewas B; Busch R; Feldmann HJ; Molls M; Lumenta CB; Schwaiger M; Grosu AL
    J Nucl Med; 2001 Aug; 42(8):1144-50. PubMed ID: 11483672
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 123I-IMT SPECT and 1H MR-spectroscopy at 3.0 T in the differential diagnosis of recurrent or residual gliomas: a comparative study.
    Plotkin M; Eisenacher J; Bruhn H; Wurm R; Michel R; Stockhammer F; Feussner A; Dudeck O; Wust P; Felix R; Amthauer H
    J Neurooncol; 2004 Oct; 70(1):49-58. PubMed ID: 15527107
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of the response to therapy of head and neck squamous cell carcinoma by using 3-[123I]iodo-L-alpha-methyl tyrosine and single photon emission tomography.
    Dierickx LO; Everaert H; Deron P; Voordeckers M; Lahoutte T; Bossuyt A
    Nucl Med Commun; 2003 Jun; 24(6):633-41. PubMed ID: 12766598
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 3-[123I]iodo-alpha-methyltyrosine and [methyl-11C]-L-methionine uptake in cerebral gliomas: a comparative study using SPECT and PET.
    Langen KJ; Ziemons K; Kiwit JC; Herzog H; Kuwert T; Bock WJ; Stöcklin G; Feinendegen LE; Müller-Gärtner HW
    J Nucl Med; 1997 Apr; 38(4):517-22. PubMed ID: 9098193
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic value positron emission tomography with [18F]fluoro-2-deoxy-D-glucose in the low-grade glioma.
    De Witte O; Levivier M; Violon P; Salmon I; Damhaut P; Wikler D; Hildebrand J; Brotchi J; Goldman S
    Neurosurgery; 1996 Sep; 39(3):470-6; discussion 476-7. PubMed ID: 8875476
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of high-risk melanoma: comparison of [18F]FDG PET and high-dose 67Ga SPET.
    Kalff V; Hicks RJ; Ware RE; Greer B; Binns DS; Hogg A
    Eur J Nucl Med Mol Imaging; 2002 Apr; 29(4):506-15. PubMed ID: 11914889
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regional methionine and glucose uptake in high-grade gliomas: a comparative study on PET-guided stereotactic biopsy.
    Goldman S; Levivier M; Pirotte B; Brucher JM; Wikler D; Damhaut P; Dethy S; Brotchi J; Hildebrand J
    J Nucl Med; 1997 Sep; 38(9):1459-62. PubMed ID: 9293808
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.